ANI Pharmaceuticals Inc (ANIP) – Strategy, SWOT and Corporate Finance Report

ANI Pharmaceuticals Inc (ANIP) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

ANI Pharmaceuticals Inc (ANI) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals. The company offers pharmaceuticals for central nervous system (CNS) disorders, gastrointestinal, cancer, ophthalmic, metabolic and other diseases. ANI also conducts business as a Contract Development and Manufacturing Organization (CDMO) supporting late-stage development to commercial manufacture of pharmaceutical products including coated/non-coated tablets and capsules, ointments, creams, non-sterile liquids, suspensions, and gels. It markets oncology products, complex formulations, hormones and steroids and controlled substances. The company sells products to wholesale distributors, group purchasing organizations, retail pharmacy chains, and other pharmaceutical companies. ANI is headquartered in Baudette, Minnesota, the US.

Scope

• Detailed information on ANI Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting ANI Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of ANI Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about ANI Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of ANI Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess ANI Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on ANI Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Apotex Inc

Amneal Pharmaceuticals Inc

Teva Pharmaceutical Industries Ltd

Glenmark Pharmaceuticals Ltd

Hikma Pharmaceuticals Plc

Viatris Inc

Sun Pharmaceutical Industries Ltd

Par Pharmaceutical Inc

Alvogen Inc

Perrigo Co Plc

Viatris Inc

Hikma Pharmaceuticals Plc

Sun Pharmaceutical Industries Ltd

Par Pharmaceutical Inc

Apotex Inc

Amneal Pharmaceuticals Inc

Rising Pharmaceuticals Inc

Teva Pharmaceutical Industries Ltd

Method Pharmaceuticals LLC

Glenmark Pharmaceuticals Ltd

Alvogen Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

ANI Pharmaceuticals Inc - Key Facts

ANI Pharmaceuticals Inc - Key Employees

ANI Pharmaceuticals Inc - Key Employee Biographies

ANI Pharmaceuticals Inc - Major Products and Services

ANI Pharmaceuticals Inc - History

ANI Pharmaceuticals Inc - Company Statement

ANI Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

ANI Pharmaceuticals Inc - Business Description

Business Segment: Generics, Established Brands, and Other Segment

Overview

Performance

Business Segment: Rare Disease Segment

Overview

Performance

Geographical Segment: Canada

Performance

Geographical Segment: United States

Performance

R&D Overview

ANI Pharmaceuticals Inc - Corporate Strategy

ANI Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

ANI Pharmaceuticals Inc - Strengths

ANI Pharmaceuticals Inc - Weaknesses

ANI Pharmaceuticals Inc - Opportunities

ANI Pharmaceuticals Inc - Threats

ANI Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

ANI Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Nov 09, 2022: ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues

Oct 24, 2022: ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET

Aug 08, 2022: ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin Gel

Jul 25, 2022: ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

Jul 18, 2022: ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary

Jun 21, 2022: ANI Pharmaceuticals adopts Veeva commercial cloud to better support rare disease patients

Jun 02, 2022: ANI Pharmaceuticals announces consolidation of manufacturing network, Capturing Operational Synergies Post Novitium Acquisition

May 20, 2022: ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

Apr 19, 2022: ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

Mar 22, 2022: ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

ANI Pharmaceuticals Inc, Key Facts

ANI Pharmaceuticals Inc, Key Employees

ANI Pharmaceuticals Inc, Key Employee Biographies

ANI Pharmaceuticals Inc, Major Products and Services

ANI Pharmaceuticals Inc, History

ANI Pharmaceuticals Inc, Other Locations

ANI Pharmaceuticals Inc, Subsidiaries

ANI Pharmaceuticals Inc, Key Competitors

ANI Pharmaceuticals Inc, Ratios based on current share price

ANI Pharmaceuticals Inc, Annual Ratios

ANI Pharmaceuticals Inc, Annual Ratios (Cont…1)

ANI Pharmaceuticals Inc, Annual Ratios (Cont…2)

ANI Pharmaceuticals Inc, Interim Ratios

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

ANI Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

ANI Pharmaceuticals Inc, Performance Chart (2018 – 2022)

ANI Pharmaceuticals Inc, Ratio Charts

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

ANI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports